Kendix (Aciclovir)

Aciclovir is a nucleoside analogue that, once phosphorylated by viral enzymes, inhibits the viral DNA polymerase. This blocks the synthesis of viral DNA, preventing the herpes virus from multiplying in the infected skin cells and allowing the immune system to clear the infection more effectively.

The dosage of Kendix is determined by the prescribing healthcare professional based on the specific indication, lesion size, and patient factors. The prescriber will provide instructions on the amount to apply, frequency, and duration of treatment.

Safety data for topical aciclovir in pregnancy and lactation are limited. Healthcare providers usually weigh the potential benefits against any unknown risks. Women who are pregnant or breastfeeding should discuss the use of Kendix with their physician before starting treatment.

To order Kendix, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and import documentation.

Kendix contains aciclovir, a well‑established antiviral with a long safety record. Compared with newer agents such as penciclovir or docosanol, aciclovir offers a broad spectrum against HSV‑1, HSV‑2 and VZV, and is often preferred for its proven efficacy in topical formulations.

Kendix should be stored at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use to maintain stability.

Kendix is applied directly to the affected skin area. Clean and dry the lesion, then spread a thin layer of the cream or ointment as directed by the prescriber, usually several times daily for the prescribed duration.

Serious but rare risks include allergic contact dermatitis, severe skin reactions such as Stevens‑Johnson syndrome, and, in exceptional cases, systemic absorption leading to renal toxicity. Patients should discontinue use and seek medical attention if they notice severe rash, swelling, or kidney‑related symptoms.

Kendix should not be used on extensive broken skin, near the eyes or mucous membranes, or by individuals with known hypersensitivity to aciclovir or any excipients in the formulation. Patients with severe renal impairment should consult a physician before use.